Revolution Medicines | 4:持股變動聲明-高管 GOLDSMITH MARK A
04/12 20:13 (美東)
Revolution Medicines | 4:持股變動聲明-董事 Patel Sushil
04/12 16:28 (美東)
Revolution Medicines | 3:首次持股聲明-高管 Wei Lin
03/29 16:58 (美東)
Revolution Medicines | 4:持股變動聲明-高管 Cislini Jeff
03/28 16:18 (美東)
Revolution Medicines | 4:持股變動聲明-高管 Kelsey Stephen Michael
03/20 16:49 (美東)
Revolution Medicines | 4:持股變動聲明-高管 Cislini Jeff
03/20 16:49 (美東)
Revolution Medicines | 4:持股變動聲明-高管 Horn Margaret A
03/20 16:48 (美東)
Revolution Medicines | 4:持股變動聲明-高管 GOLDSMITH MARK A
03/20 16:48 (美東)
Revolution Medicines | 4:持股變動聲明-高管 Anders Jack
03/20 16:48 (美東)
Revolution Medicines | 4:持股變動聲明-高管 Horn Margaret A
03/13 16:36 (美東)
Revolution Medicines | 4:持股變動聲明-高管 Anders Jack
03/05 17:02 (美東)
Revolution Medicines | 4:持股變動聲明-高管 Cislini Jeff
03/05 17:00 (美東)
Revolution Medicines | 4:持股變動聲明-高管 GOLDSMITH MARK A
03/05 16:59 (美東)
Revolution Medicines | 4:持股變動聲明-高管 Horn Margaret A
03/05 16:59 (美東)
Revolution Medicines | 4:持股變動聲明-高管 Kelsey Stephen Michael
03/05 16:59 (美東)
Revolution Medicines | 4:持股變動聲明-高管 Wang Xiaolin
03/05 16:57 (美東)
Revolution Medicines | SC 13G/A:超過5%持股股東披露文件(修正)-EcoR1 Capital, LLC(0.1%),Oleg Nodelman(0.1%)等
02/14 18:33 (美東)
Revolution Medicines | SC 13G/A:超過5%持股股東披露文件(修正)-BVF Partners L.P.(3.6%),BVF Inc.(3.6%)等
02/14 09:31 (美東)
Revolution Medicines | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(8.93%)
02/13 22:37 (美東)
Revolution Medicines | SC 13G/A:超過5%持股股東披露文件(修正)-BB Biotech AG(3.1%),Biotech Target N.V.(3.1%)等
02/13 06:10 (美東)
暫無數據
暫無數據